Biological Heterogeneity in Susceptibility to Glucocorticoid-Induced Bone Loss: Short- and Long-Term Hip BMD Trajectories
The findings confirm the association between initial GC exposure and significant bone loss. The heterogeneity in individual responses emphasizes the need for early monitoring and personalized approaches in managing bone health for patients undergoing GC treatment.
Authors
- Katrine Hass Rubin (ORCID: https://orcid.org/0000-0001-5045-536X)
- Bo Abrahamsen (ORCID: https://orcid.org/0000-0002-2730-6080)
- Benjamin Bakke Hansen (ORCID: https://orcid.org/0009-0006-5415-6811)
- Anne Pernille Hermann (ORCID: https://orcid.org/0000-0001-6701-0981)
- Catharina Vind Nielsen (ORCID: https://orcid.org/0000-0001-5497-8934)
- Morten Frost Nielsen
Institutions
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Region of Southern Denmark (DK)
- Hospital South West Jutland (DK)
- Holbæk Sygehus (DK)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1210/clinem/dgae832
- Citations
- 2
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.96